Deputy Director of the Breast Medical Oncology Department, Deputy Director of the Internal Medicine Teaching and Research Office, Chief Physician, Associate Professor, Doctorate Degree, Master's Supervisor. Graduated from Beijing Medical University (now Peking University Health Science Center) in 1993 with a degree in Clinical Medicine. Has been engaged in the medical treatment of breast cancer for many years, with extensive clinical experience and relevant scientific research theoretical knowledge, especially in postoperative and recurrent/metastatic breast cancer. In 2011, served as a visiting scholar at the National Cancer Institute (NCI) of the National Institutes of Health (NIH) for one year. Published over 20 papers, led one National Natural Science Foundation of China project and one project under the Science and Technology Activities Merit-Based Funding for Returned Overseas Personnel, participated in multiple ministerial and municipal-level scientific research projects, and co-translated/compiled several oncology monographs. Chairman of the Breast Cancer Precision Targeted Diagnosis and Treatment Committee of the Beijing Cancer Prevention and Treatment Society, Member of the CSCO Breast Cancer Expert Committee, Standing Committee Member of the Breast Disease Research Center of the Chinese Women Physicians Association, Standing Committee Member of the Internal Medicine Professional Committee of the Beijing Breast Disease Prevention and Treatment Society, Standing Committee Member of the Health Management Professional Committee of the Beijing Breast Disease Prevention and Treatment Society, Standing Committee Member of the Breast Disease Professional Committee of the China Medical Education Association, Member of the Beijing Standardized Residency Training Professional Committee, Standing Committee Member and Deputy Secretary-General of the Breast Disease Branch of the China International Exchange and Promotive Association for Medical and Health Care, and Deputy Chairman of the National Expert Committee for Precision Prevention and Treatment of Breast Cancer of the Beijing Association of Chinese Medicine and Chronic Disease Prevention and Treatment. Mainly specializes in comprehensive breast cancer treatment based on chemotherapy, endocrine therapy, and targeted therapy. Published Papers: 1. Shao B1, Song G#, Li H, Dil L, Jiang H, Liang X, Yan Y, Zhang R, Ran R, Wang J, Liu X, You M. Combination versus Sequential Paclitaxel plus Gemcitabine as First-line Chemotherapy for Women with Metastatic Breast Cancer: A Prospective Randomized Phase II Study. J BUON. 2018 Nov-Dec;23(6):1583-1590. (IF 1.76) 2. Lei Wen, Song Guohong, Li Huiping, Zhang Ruyan, Shao Bin, Wang Huan, Ran Ran. Efficacy and Safety Analysis of Endostar Combined with Chemotherapy in the Treatment of Advanced Refractory Breast Cancer. Cancer Progress, 2018, 16(02):210-213. 3. Zhao Dan/Song Guohong (co-first author), Li Huiping, Shao Bin, Zhang Ruyan, Yan Ying, Kong Weiyao, Liu Xiaoran, Liu Yaxin, Di Lijun, Ran Ran, Wang Huan, Zhang Jiayang. Clinical Characteristics and Overall Survival Analysis of Recurrent and Metastatic Triple-Negative Breast Cancer. Cancer Progress, 2016, 14(12): 1179-1183. 4. Song Guohong, Di Lijun, Shao Bin, Zhang Ruyan, Ran Ran, Wang Huan, Lei Wen, Wan Fengling, Li Huiping. Efficacy Observation of Fulvestrant 500 mg in the Treatment of Hormone Receptor-Positive Recurrent and Metastatic Breast Cancer. Chinese Journal of Cancer, 2016, 26(11): 957-960. 5. GUOHONG SONG, HSUAN HSIAO, JINLIAN L. WANG, CIARAN MANNION, ALEXANDER STOJADINOVIC, ITZHAK AVITAL, SIDNEY W. FU, JEFFREY MASON, WEN CHEN, ANAHID JEWETT, HUIPING LI and YAN-GAO MAN. Differential Impact of Tumor Infiltrating Immune Cells on Basal and Luminal Cells: Implications for Tumor Invasion and Metastasis. Anticancer Res, 2014; 34 (11): 6363-6380. (IF 1.87) 6. Guohong Song, Xiaoli Wang, Jun Jia, Yanhua Yuan, Fengling Wan, Xinna Zhou, Huabing Yang, Jun Ren, Jiezhun Gu, Herbert Kim Lyerly. Elevated level of peripheral CD8+CD28- T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy. Cancer Immunology Immunotherapy, 2013; 62: 1123–1130. (IF 3.7) 7. Song G, Ren J, Stojadinovic A, et al. Conjunction of tumor cells with lymphocytes: Implications for tumor invasion and metastasis. Cancer Epidemiol, 2012; 36: 354–363. 8. Liang Xu, Song Guohong, Di Lijun, et al. Protective effect of hematopoietic stem cells on chemotherapy-induced hepatotoxicity: Analysis of 115 cases. Chinese Journal of Drug Application and Monitoring, 2012, 9(1): 5-7. 9. Jiang Hanfang, Song Guohong, Che Li, et al. Clinical analysis of 23 cases of advanced metastatic breast cancer treated with oral low-dose cyclophosphamide metronomic therapy. Chinese Journal of Clinical Oncology, 2011, 38(2): 104-107. 10. Yan-gao Man, Mina Izadjoo, Guohong Song, et al. In Situ Malignant Transformation and Progenitor-Mediated Cell Budding: Two Different Pathways for Breast Ductal and Lobular Tumor Invasion. J Cancer 2011; 2: 401-412. 11. Song Guohong, Ren Jun, Di Lijun, et al. Efficacy observation of high-dose chemotherapy supported by peripheral blood hematopoietic stem cells in the treatment of young patients with metastatic breast cancer. Chinese Journal of Cancer, 2011, 21(1): 56-60. 12. Guohong Song, Jun Ren, Lijun Di, et al. Decrease of Peripheral Blood CD8+/CD28- Suppressor T Cell Followed by Dendritic Cells Immunomodulation among Metastatic Breast Cancer Patients. Chin J Cancer Res, 2010, 22(4): 310-315. 13. Song Guohong, Di Lijun, Wan Fengling, et al. Clinical application of exemestane in advanced breast cancer patients who failed non-steroidal aromatase inhibitor therapy. Chinese Journal of Cancer, 2010, 20(7): 535-538. 14. Guohong Song, Jun Ren, Lijian Zhang, Lijun Di, Jing Yu, Jun Jia. Low correspondence of EGFR mutations in tumor tissue and paired serum of non-small-cell lung cancer patients. Chin J Cancer Res, 2010, 22(1): 27-31. 15. Song Guohong, Ren Jun, Zhang Lijian, et al. A rapid and simple detection method for major mutation types of the epidermal growth factor receptor gene in non-small cell lung cancer. Chinese Journal of Cancer, 2009, 19(5): 347-5. 16. Song Guohong, Di Lijun, Ren Jun, et al. Study on epidermal growth factor receptor gene mutations in Chinese patients with non-small cell lung cancer. Modern Oncology Medicine, 2008, 16(4): 553-556. 17. Di Lijun, Song Guohong, Yu Jing, et al. Clinical observation of letrozole in the treatment of postmenopausal advanced breast cancer. Modern Oncology Medicine, 2006, 14(4): 464-465. 18. Song Guohong, Di Lijun, Nie Jun, et al. Efficacy observation of Aidi injection combined with chemotherapy in the treatment of advanced malignant tumors. Journal of Cancer Prevention and Treatment, 2004, 11(6): 650-651. 19. Song Guohong, Liu Shujun, Nie Jun, et al. Investigation of tumor-associated anemia and its impact on the quality of life of cancer patients. Journal of Cancer Prevention and Treatment, 2003, 10 (11): 1186-1188. 20. Song Guohong, Liu Shujun, Di Lijun, et al. Efficacy observation of recombinant human erythropoietin in the treatment of chemotherapy-related anemia. Chinese Journal of Cancer, 2002, 12(5): 428-430. 21. Song Guohong, Huang Li, Liu Shujun, et al. Efficacy observation of taxane drugs in the treatment of advanced malignant tumors. Chinese Journal of Clinical Oncology and Rehabilitation, 2002, 9(1): 109-110.